VAPB and amyotrophic lateral sclerosis: We also generated an iPSC line from an ALS patient harboring the VAPB P56S mutation and an isogenic control through CRISPR-Cas9 technology, and we were able to validate these findings in the ALS-iPSC-derived motor neurons.